Cardiovascular Therapeutics 2007
DOI: 10.1016/b978-1-4160-3358-5.50007-3
|View full text |Cite
|
Sign up to set email alerts
|

Tools for Assessment of Cardiovascular Tests and Therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 208 publications
0
1
0
Order By: Relevance
“…Although a p value <0.05 is at the significant level, in clinical medicine it is advisable to use p ≤ 0.02 as a level of significant treatment effect. • Statements describing treatment effect (Antman et al 2002 ):…”
Section: Antiplatelet Agents Anticoagulants Factor Xa Inhibitors Amentioning
confidence: 99%
“…Although a p value <0.05 is at the significant level, in clinical medicine it is advisable to use p ≤ 0.02 as a level of significant treatment effect. • Statements describing treatment effect (Antman et al 2002 ):…”
Section: Antiplatelet Agents Anticoagulants Factor Xa Inhibitors Amentioning
confidence: 99%